The FDA has approved an oral rotavirus vaccine (RotaTeq) and desloratadine 2.5-mg plus pseudoephedrine sulfate 120-mg extended-release tablets (Clarinex-D 12-Hour). (CME,CE)
Medscape Medical NewsLaurie Barclay,Yael Waknine
Click Here to read the entire article...